Viewing nowCombinationRitovajet Tablets 10/40 Milligrams (Ezetimibe, Atorvastatin Calcium Hydrate)
Ezetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.

MFDS item code 202101431 · Approved 2021.02.18 · Insurance code 641607540
Improvement of primary and homozygous familial hypercholesterolemia and mixed dyslipidemia
This medication helps to reduce elevated total cholesterol, LDL-cholesterol, apolipoprotein B, triglycerides, and non-HDL-cholesterol in patients with primary hypercholesterolemia and mixed dyslipidemia, while also increasing HDL-cholesterol. It is particularly used as an adjunct treatment in patients with homozygous familial hypercholesterolemia, either in conjunction with other therapies or as an alternative. This medication is administered alongside appropriate dietary changes and lifestyle modifications, and is effective as part of a comprehensive treatment plan rather than as a standalone treatment. It also assists in safely and effectively controlling lipid levels in patients at high risk for cardiovascular disease. Prior to administration, it is important to identify and treat any underlying causes of dyslipidemia as necessary. This medication is used to improve blood lipid levels associated with dyslipidemia, thereby enhancing patient health.
Administer this medicine once daily, regardless of meals. Patients should continue to follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dose of this medicine should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range for this medicine is 10/10mg∼10/80mg once daily. The recommended starting dose is 10/10mg or 10/20mg once daily. For patients requiring a greater reduction in LDL cholesterol (at least 55%), a starting dose of 10/40mg once daily is recommended. After starting treatment or adjusting the dose, check blood lipid levels at intervals of at least 2 weeks and adjust the dose accordingly. Homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40mg or 10/80mg once daily. This medicine is administered as an adjunct to other lipid-lowering therapies (e.g., LDL apheresis) or when other lipid-lowering therapies are not useful.
This medication can rarely cause muscle damage resulting in severe kidney problems; therefore, if severe muscle pain or weakness occurs, consult a physician immediately. Persons with allergies to this medication's active ingredients or components, those with liver issues or elevated liver enzyme levels, individuals with muscle disorders, pregnant women or women who may become pregnant, and nursing mothers should not take this medication. Individuals at higher risk for myopathy, such as those with alcohol dependence, poor liver function, kidney issues, or hypothyroidism, as well as the elderly, should be particularly cautious when taking this medication, and dosage adjustments or monitoring may be needed at the physician's discretion. This medication can impact liver function, so it is important to undergo liver function tests before and during administration, and to promptly inform a physician if symptoms of liver damage (e.g., jaundice, nausea, vomiting, fatigue) appear. During treatment with this medication, if muscle pain, weakness, fatigue, fever, or other symptoms develop, consult a physician immediately and receive muscle enzyme tests if necessary. This medication may interact with other drugs; therefore, be sure to inform your doctor or pharmacist if taking specific antibiotics, antivirals, immunosuppressants, fibrates, etc. Women of childbearing age should use proper contraceptive methods to avoid pregnancy while taking this medication, and if pregnancy is confirmed, they should stop taking it immediately and consult a physician. The safety and efficacy of this medication in children have not been established, and it is generally not recommended for them. Although older adults are at higher risk for myopathy and should exercise caution when taking, special dosage adjustments are usually not necessary. In the case of overdose, there is no specific antidote, so management should focus on symptomatic treatment and monitoring of liver function and muscle enzymes.
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius. Proper storage ensures the medication's effectiveness.
Yellow oval film-coated tablet
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Daewong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.